Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuro Ishibashi

Showing results (1-10 of 365) with videos related to

Pageof 37
Sort By:
Nippon Ganka Gakkai Zasshi|May 10, 2012
[Comprehensive strategy for retinal neuroprotection. Challenging the clinical application]Tatsuro Ishibashi
Japanese Journal of Ophthalmology|July 18, 2013
Maintenance therapy with pegaptanib sodium for neovascular age-related macular degeneration: an exploratory study in Japanese patients (LEVEL-J study)Tatsuro Ishibashi,
Nippon Ganka Gakkai Zasshi|April 8, 2009
[Life-style related diseases and the eye]Tatsuro Ishibashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Chronic complications due to diabetes mellitus: Pathology of diabetic retinopathy]Yasuaki Hata, Tatsuro Ishibashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 8, 2005
[Pathology of diabetic retinopathy]Yasuaki Hata, Tatsuro Ishibashi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|January 14, 2011
[Neuroprotective gene therapy to treat patients with retinitis pigmentosa]Yasuhiro Ikeda, Tatsuro Ishibashi
Developments in Ophthalmology|June 7, 2008
Brilliant blue in vitreoretinal surgeryHiroshi Enaida, Tatsuro Ishibashi
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 23, 2009
Visualizing vitreous in vitrectomy by triamcinoloneTaiji Sakamoto, Tatsuro Ishibashi
Retina (Philadelphia, Pa.)|January 18, 2011
Hyalocytes: essential cells of the vitreous cavity in vitreoretinal pathophysiology?Taiji Sakamoto, Tatsuro Ishibashi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|November 9, 2013
[Development of novel molecular targeting therapy for diabetic retinopathy based on genome-wide gene expression profiling]Shigeo Yoshida, Tatsuro Ishibashi
Pageof 37

Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Nippon Ganka Gakkai Zasshi|May 10, 2012
[Comprehensive strategy for retinal neuroprotection. Challenging the clinical application]Tatsuro Ishibashi
Japanese Journal of Ophthalmology|July 18, 2013
Maintenance therapy with pegaptanib sodium for neovascular age-related macular degeneration: an exploratory study in Japanese patients (LEVEL-J study)Tatsuro Ishibashi,
Nippon Ganka Gakkai Zasshi|April 8, 2009
[Life-style related diseases and the eye]Tatsuro Ishibashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Chronic complications due to diabetes mellitus: Pathology of diabetic retinopathy]Yasuaki Hata, Tatsuro Ishibashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 8, 2005
[Pathology of diabetic retinopathy]Yasuaki Hata, Tatsuro Ishibashi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|January 14, 2011
[Neuroprotective gene therapy to treat patients with retinitis pigmentosa]Yasuhiro Ikeda, Tatsuro Ishibashi
Developments in Ophthalmology|June 7, 2008
Brilliant blue in vitreoretinal surgeryHiroshi Enaida, Tatsuro Ishibashi
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 23, 2009
Visualizing vitreous in vitrectomy by triamcinoloneTaiji Sakamoto, Tatsuro Ishibashi
Retina (Philadelphia, Pa.)|January 18, 2011
Hyalocytes: essential cells of the vitreous cavity in vitreoretinal pathophysiology?Taiji Sakamoto, Tatsuro Ishibashi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|November 9, 2013
[Development of novel molecular targeting therapy for diabetic retinopathy based on genome-wide gene expression profiling]Shigeo Yoshida, Tatsuro Ishibashi
Pageof 37